FDA Approves First Drug Targeting Sleep in Fibromyalgia

Tonmya, a once-daily sublingual tablet, offers a new nonopioid option for managing fibromyalgia symptoms

The FDA has approved cyclobenzaprine hydrochloride sublingual tablets (Tonmya, Tonix Pharmaceuticals) as the first new therapy for fibromyalgia in over 15 years. The medication is designed to improve nonrestorative sleep, a key driver of pain, fatigue, and cognitive symptoms in this chronic condition.

Study Details

Fibromyalgia affects more than 10 millio…